EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

Clinical & Translational Immunology

ISSN 2050-0068 · Wiley

Latest articles

  1. Randomised controlled phase I trial of a SARS ‐ CoV ‐2 monoclonal antibody

    Wen Shi Lee, Kevin J Selva, Timothy E Schlub, Jennifer Audsley, Janavi S Rambhatla, Robyn Esterbauer, Jennifer A Juno, Andrew Kelly, Ellie Reilly, Thakshila Amarasena, Sarah Lee, Hyon‐Xhi Tan, Chee Wah Tan, Lin‐Fa Wang, Christina C Chang, Michael Gerometta, Judith A Scoble, Patrick F James, Arnold Reynaldi, Miles P Davenport, Kym Hoger, Karen Hughes, Martina L Jones, Ben Hughes, Adam K Wheatley, Stephen J Kent

    Published: 2026-11DOI: 10.1002/cti2.70126

  2. Serum sodium as a potential biomarker for immunotherapy response in metastatic RCC —real‐world evidence from a German multicentre cohort

    Alix Tschirhart, Alexander Cox, Benedikt Hoeh, Cristina Cano Garcia, Angelika Mattigk, Marcus Sondermann, Thomas Büttner, Marcel Schwinger, Jonathan Vollemaere, Kati Erdmann, Philipp Schmucker, Luka Flegar, Friedemann Zengerling, Severine Banek, Johannes Huber, Philip Zeuschner, Charis Kalogirou, Niklas Klümper, Jonas Saal

    Published: 2026-11DOI: 10.1002/cti2.70130

  3. Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

    Daan A R Castelijn, Jolanda M W van de Water, Laura R de Baaij, Bridget S McGlinchy, Michelle van Leeuwen, Sander P J Joosten, Nikita Alberts, Margherita Rossi, Martine Reijm, Jolien C Hollander, Petra Bonnet, Yvonne M C Kooy‐Winkelaar, Frits Koning, Steven T Pals, Gerd Bouma, Chris J L M Meijer, Hetty J Bontkes, Chris J J Mulder, Saskia A G M Cillessen

    Published: 2026-05DOI: 10.1002/cti2.70099

Volumes

2026 · 542025 · 462024 · 682023 · 472022 · 752021 · 1282020 · 1322019 · 452018 · 302017 · 432016 · 662015 · 262014 · 212013 · 62012 · 2

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.